ZETAMAST Trademark

Trademark Overview


On Wednesday, January 4, 2023, a trademark application was filed for ZETAMAST with the United States Patent and Trademark Office. The USPTO has given the ZETAMAST trademark a serial number of 97741225. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, June 17, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The ZETAMAST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of tumor and metastatic tumor diseases; pharmaceutical preparations for the treatment of tumor and metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, tumor and metastatic tumors and lesions
zetamast

General Information


Serial Number97741225
Word MarkZETAMAST
Filing DateWednesday, January 4, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of tumor and metastatic tumor diseases; pharmaceutical preparations for the treatment of tumor and metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, tumor and metastatic tumors and lesions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events


Event DateEvent Description
Saturday, January 7, 2023NEW APPLICATION ENTERED
Monday, January 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2023ASSIGNED TO EXAMINER
Thursday, October 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU EXTENSION 1 FILED
Monday, June 17, 2024SOU EXTENSION 1 GRANTED